GlassScriptPhysician profile
Willis M Wu
NPI 1184840514
$55,949.02
in general payments reported to CMS, 2019-2025
20 companies · $549 in 2025
The $549 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,547 · 2020: $2,897 · 2021: $6,803 · 2022: $12K · 2023: $20K · 2024: $6,795 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $3,799 · Consulting Fee: $1,875 · Food and Beverage: $1,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,100.00 |
| Travel and Lodging | $3,799.23 |
| Consulting Fee | $1,875.00 |
| Food and Beverage | $1,864.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $30,416.55 | 2021-2024 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $8,270.74 | 2019-2025 | Carpentier-Edwards Physio II Annuloplasty Ring |
| Abbott Laboratories | $6,189.98 | 2019-2025 | Amplatzer Talisman, Amplatzer Amulet, Triclip |
| Cordis US Corp. | $3,875.00 | 2022-2023 | Rain Sheath |
| Boston Scientific Corporation | $3,861.26 | 2019-2025 | Intracept, Watchman Flx, Watchman Access System |
| Ancora Heart, INC. | $2,841.86 | 2024 | Accucinch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.13 | 2021-2025 | Lifevest |
| Pfizer INC. | $96.94 | 2023 | |
| Janssen Pharmaceuticals, INC | $76.48 | 2021-2022 | |
| Medtronic Vascular, INC. | $32.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.18 | 2020 | |
| Philips North America LLC | $23.85 | 2024 | (Bq9) Coronary Ivus |
| Nevro Corp. | $22.85 | 2019 | |
| Kestra Medical Technology Services, INC. | $20.25 | 2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $16.85 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.59 | 2020 | |
| Terumo Medical Corporation | $13.90 | 2024 | Metacross Otw |
| Heartflow, INC. | $12.74 | 2020 | |
| Abiomed | $11.88 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willis Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.